Copyright Reports & Markets. All rights reserved.

Global Antibody Drug Conjugates Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Antibody Drug Conjugates Market Overview

      • 1.1 Product Overview and Scope of Antibody Drug Conjugates
      • 1.2 Antibody Drug Conjugates Segment by Type
        • 1.2.1 Global Antibody Drug Conjugates Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Adcetris
        • 1.2.3 Kadcyla
      • 1.3 Antibody Drug Conjugates Segment by Application
        • 1.3.1 Antibody Drug Conjugates Consumption Comparison by Application (2014-2025)
        • 1.3.2 Breast Cancer
        • 1.3.3 Lymphoma
      • 1.4 Global Antibody Drug Conjugates Market by Region
        • 1.4.1 Global Antibody Drug Conjugates Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Antibody Drug Conjugates Market Size
        • 1.5.1 Global Antibody Drug Conjugates Revenue (2014-2025)
        • 1.5.2 Global Antibody Drug Conjugates Production (2014-2025)

      2 Global Antibody Drug Conjugates Market Competition by Manufacturers

      • 2.1 Global Antibody Drug Conjugates Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Antibody Drug Conjugates Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Antibody Drug Conjugates Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Antibody Drug Conjugates Production Sites, Area Served, Product Types
      • 2.5 Antibody Drug Conjugates Market Competitive Situation and Trends
        • 2.5.1 Antibody Drug Conjugates Market Concentration Rate
        • 2.5.2 Antibody Drug Conjugates Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Antibody Drug Conjugates Production Market Share by Regions

      • 3.1 Global Antibody Drug Conjugates Production Market Share by Regions
      • 3.2 Global Antibody Drug Conjugates Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Antibody Drug Conjugates Production
        • 3.4.1 North America Antibody Drug Conjugates Production Growth Rate (2014-2019)
        • 3.4.2 North America Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Antibody Drug Conjugates Production
        • 3.5.1 Europe Antibody Drug Conjugates Production Growth Rate (2014-2019)
        • 3.5.2 Europe Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Antibody Drug Conjugates Production (2014-2019)
        • 3.6.1 China Antibody Drug Conjugates Production Growth Rate (2014-2019)
        • 3.6.2 China Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Antibody Drug Conjugates Production (2014-2019)
        • 3.7.1 Japan Antibody Drug Conjugates Production Growth Rate (2014-2019)
        • 3.7.2 Japan Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Antibody Drug Conjugates Consumption by Regions

      • 4.1 Global Antibody Drug Conjugates Consumption by Regions
      • 4.2 North America Antibody Drug Conjugates Consumption (2014-2019)
      • 4.3 Europe Antibody Drug Conjugates Consumption (2014-2019)
      • 4.4 China Antibody Drug Conjugates Consumption (2014-2019)
      • 4.5 Japan Antibody Drug Conjugates Consumption (2014-2019)

      5 Global Antibody Drug Conjugates Production, Revenue, Price Trend by Type

      • 5.1 Global Antibody Drug Conjugates Production Market Share by Type (2014-2019)
      • 5.2 Global Antibody Drug Conjugates Revenue Market Share by Type (2014-2019)
      • 5.3 Global Antibody Drug Conjugates Price by Type (2014-2019)
      • 5.4 Global Antibody Drug Conjugates Production Growth by Type (2014-2019)

      6 Global Antibody Drug Conjugates Market Analysis by Applications

      • 6.1 Global Antibody Drug Conjugates Consumption Market Share by Application (2014-2019)
      • 6.2 Global Antibody Drug Conjugates Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Antibody Drug Conjugates Business

      • 7.1 F. Hoffman-La Roche
        • 7.1.1 F. Hoffman-La Roche Antibody Drug Conjugates Production Sites and Area Served
        • 7.1.2 Antibody Drug Conjugates Product Introduction, Application and Specification
        • 7.1.3 F. Hoffman-La Roche Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Novartis AG
        • 7.2.1 Novartis AG Antibody Drug Conjugates Production Sites and Area Served
        • 7.2.2 Antibody Drug Conjugates Product Introduction, Application and Specification
        • 7.2.3 Novartis AG Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Takeda Pharmaceutical
        • 7.3.1 Takeda Pharmaceutical Antibody Drug Conjugates Production Sites and Area Served
        • 7.3.2 Antibody Drug Conjugates Product Introduction, Application and Specification
        • 7.3.3 Takeda Pharmaceutical Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Pfizer
        • 7.4.1 Pfizer Antibody Drug Conjugates Production Sites and Area Served
        • 7.4.2 Antibody Drug Conjugates Product Introduction, Application and Specification
        • 7.4.3 Pfizer Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Seattle Genetics
        • 7.5.1 Seattle Genetics Antibody Drug Conjugates Production Sites and Area Served
        • 7.5.2 Antibody Drug Conjugates Product Introduction, Application and Specification
        • 7.5.3 Seattle Genetics Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Genentech
        • 7.6.1 Genentech Antibody Drug Conjugates Production Sites and Area Served
        • 7.6.2 Antibody Drug Conjugates Product Introduction, Application and Specification
        • 7.6.3 Genentech Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Immunogen
        • 7.7.1 Immunogen Antibody Drug Conjugates Production Sites and Area Served
        • 7.7.2 Antibody Drug Conjugates Product Introduction, Application and Specification
        • 7.7.3 Immunogen Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Progenics Pharmaceuticals
        • 7.8.1 Progenics Pharmaceuticals Antibody Drug Conjugates Production Sites and Area Served
        • 7.8.2 Antibody Drug Conjugates Product Introduction, Application and Specification
        • 7.8.3 Progenics Pharmaceuticals Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Bayer Healthcare Pharmaceuticals
        • 7.9.1 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Production Sites and Area Served
        • 7.9.2 Antibody Drug Conjugates Product Introduction, Application and Specification
        • 7.9.3 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Antibody Drug Conjugates Manufacturing Cost Analysis

      • 8.1 Antibody Drug Conjugates Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Antibody Drug Conjugates
      • 8.4 Antibody Drug Conjugates Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Antibody Drug Conjugates Distributors List
      • 9.3 Antibody Drug Conjugates Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Antibody Drug Conjugates Market Forecast

      • 11.1 Global Antibody Drug Conjugates Production, Revenue Forecast
        • 11.1.1 Global Antibody Drug Conjugates Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Antibody Drug Conjugates Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Antibody Drug Conjugates Price and Trend Forecast (2019-2025)
      • 11.2 Global Antibody Drug Conjugates Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Antibody Drug Conjugates Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Antibody Drug Conjugates Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Antibody Drug Conjugates Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Antibody Drug Conjugates Production, Revenue Forecast (2019-2025)
      • 11.3 Global Antibody Drug Conjugates Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Antibody Drug Conjugates Consumption Forecast (2019-2025)
        • 11.3.2 Europe Antibody Drug Conjugates Consumption Forecast (2019-2025)
        • 11.3.3 China Antibody Drug Conjugates Consumption Forecast (2019-2025)
        • 11.3.4 Japan Antibody Drug Conjugates Consumption Forecast (2019-2025)
      • 11.4 Global Antibody Drug Conjugates Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Antibody Drug Conjugates Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. 
        The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market.

        The global Antibody Drug Conjugates market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Antibody Drug Conjugates volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody Drug Conjugates market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        F. Hoffman-La Roche
        Novartis AG
        Takeda Pharmaceutical
        Pfizer
        Seattle Genetics
        Genentech
        Immunogen
        Progenics Pharmaceuticals
        Bayer Healthcare Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Adcetris
        Kadcyla

        Segment by Application
        Breast Cancer
        Lymphoma

        Buy now